PharmaCyte Biotech, Inc.
What this means
- Exchange listing at riskOn Dec 5, 2025 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.
- Change of auditorOn Oct 16, 2026 the company reported a change of its independent accountant (Item 4.01). The 8-K must say whether there were disagreements with the former auditor.
- Net loss in 2025Net loss of $19.4M for the year (2024: $30.7M).
What to do next
- NT 10-K: what a late-filing notice actually meansguide
- How to check a US company before you sign a contractguide
- How to read an 8-K: what customers and creditors should checkguide
Guides from the Companies Daily newsroom, picked for what the register shows.
Financials from XBRL
| Calendar-year frame | 2025 | 2024 |
|---|---|---|
| Revenue | $0 | $0 |
| Net income (loss) | −$19.4M | $30.7M |
| Total assets | $55.9M | $43.8M |
| Total liabilities | $16.5M | $3.6M |
| Stockholders’ equity | $38.1M | $40.3M |
| Cash and equivalents | $20.2M | $16.4M |
From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends April 30. Check the annual report for the exact figures and periods.
- Name as filed
- PharmaCyte Biotech, Inc.
Formerly: Nuvilex, Inc. - CIK
- 0001157075
- Tickers
- PMCB
- Kind of filer
- SEC-reporting company
Non-accelerated filer; Smaller reporting company - Status
- Filing with the SEC
- State of incorporation
- Nevada
- Industry (SIC)
- 2836 · Biological products, (no diagnostic substances)
Industry: D · Manufacturing → - Fiscal year ends
- April 30
- Last annual report
- 10-K for the period ended Apr 30, 2026
- Last quarterly report
- 10-Q for the quarter ended Jul 31, 2026
- Bankruptcy reported
- Not in our data
- Last edition event
- Oct 16, 2026
Filing history
Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.
- Form 8-K · items 4.01, 9.01 · filed Oct 16, 2026 · filing
- Form 10-Q · filed Sep 14, 2026 · filing
- Form 10-K · filed Jul 29, 2026 · filing
- Form 8-K · items 5.02, 5.07, 9.01 · filed Apr 2, 2026 · filing
- Form 10-Q · filed Mar 17, 2026 · filing
- Form 10-Q · filed Dec 18, 2025 · filing
- Form NT 10-Q · filed Dec 15, 2025 · filing
- Form 8-K · items 3.01 · filed Dec 5, 2025 · filing
- Form 8-K · items 5.02, 5.07, 9.01 · filed Oct 31, 2025 · filing
- Form 10-Q · filed Sep 15, 2025 · filing
- Form 8-K · items 1.01, 2.01, 7.01, 9.01 · filed Sep 5, 2025 · filing
- Form D · items 06b · filed Sep 4, 2025 · filing
- Form 10-K · filed Aug 11, 2025 · filing
- Form NT 10-K · filed Jul 29, 2025 · filing
- Form 10-Q · filed Mar 17, 2025 · filing
- Form 8-K · items 4.01, 9.01 · filed Feb 26, 2025 · filing
- Form 10-Q · filed Dec 13, 2024 · filing
- Form NT 10-Q · filed Sep 17, 2024 · filing
- Form 10-Q · filed Sep 17, 2024 · filing
- Form 10-K · filed Aug 13, 2024 · filing
- Form NT 10-K · filed Jul 29, 2024 · filing
- Form SC 13D · filed May 30, 2024 · filing
- Form 8-K · items 1.01, 2.01, 8.01, 9.01 · filed May 23, 2024 · filing
- Form 10-Q · filed Mar 18, 2024 · filing
- Form 10-Q · filed Dec 15, 2023 · filing
- Form 8-K · items 5.02 · filed Nov 24, 2023 · filing
- Form SC 13D · filed Nov 22, 2023 · filing
- Form 8-K · items 4.01 · filed Nov 9, 2023 · filing
- Form 10-Q · filed Sep 18, 2023 · filing
- Form NT 10-Q · filed Sep 15, 2023 · filing
- Form 8-K · items 4.01, 9.01 · filed Aug 4, 2023 · filing
- Form 10-K · filed Jul 31, 2023 · filing
- Form 10-Q · filed Mar 16, 2023 · filing